DTx Pharma is based in San Diego. It has raised $114M in total funding. Latest round: Series B.
DTx Pharma is based in San Diego. DTx Pharma has raised $114M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in February 2021. The round record for DTx Pharma runs through 2021; nothing later has been disclosed. Investors on record include RA Capital Management, Access Biotechnology, Surveyor Capital, Cormorant Asset Management, Janus Henderson Investors, Logos Capital and 4 others. 10 distinct backers are named across the disclosed rounds.
Every DTx Pharma figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Diego at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026